MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 147 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $157,000 | -24.5% | 11,264 | 0.0% | 0.12% | -27.4% |
Q3 2017 | $208,000 | +9.5% | 11,264 | 0.0% | 0.16% | +5.8% |
Q2 2017 | $190,000 | +26.7% | 11,264 | 0.0% | 0.16% | +28.1% |
Q1 2017 | $150,000 | -11.8% | 11,264 | 0.0% | 0.12% | -10.4% |
Q4 2016 | $170,000 | +28.8% | 11,264 | 0.0% | 0.14% | +20.5% |
Q3 2016 | $132,000 | +8.2% | 11,264 | 0.0% | 0.11% | +7.7% |
Q2 2016 | $122,000 | +17.3% | 11,264 | 0.0% | 0.10% | +16.9% |
Q1 2016 | $104,000 | -37.7% | 11,264 | 0.0% | 0.09% | -38.2% |
Q4 2015 | $167,000 | -9.7% | 11,264 | 0.0% | 0.14% | -14.3% |
Q3 2015 | $185,000 | -28.0% | 11,264 | 0.0% | 0.17% | -22.6% |
Q2 2015 | $257,000 | +131.5% | 11,264 | +54.8% | 0.22% | +130.9% |
Q1 2015 | $111,000 | +26.1% | 7,275 | 0.0% | 0.09% | +32.4% |
Q4 2014 | $88,000 | +7.3% | 7,275 | 0.0% | 0.07% | +2.9% |
Q3 2014 | $82,000 | -6.8% | 7,275 | 0.0% | 0.07% | -5.5% |
Q2 2014 | $88,000 | +3.5% | 7,275 | 0.0% | 0.07% | +1.4% |
Q1 2014 | $85,000 | – | 7,275 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MONROE HALL ASSET MANAGEMENT LLC | 200,000 | $3,282,000 | 1.60% |
SECTOR GAMMA AS | 350,920 | $5,759,000 | 1.56% |
Opaleye Management Inc. | 160,000 | $2,626,000 | 1.29% |
Visium Asset Management, LP | 5,398,088 | $88,583,000 | 1.21% |
Palo Alto Investors LP | 1,455,176 | $23,879,000 | 1.15% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 4,597,915 | $75,452,000 | 0.84% |
Sivik Global Healthcare LLC | 90,000 | $1,477,000 | 0.72% |
Campbell & CO Investment Adviser LLC | 45,887 | $753,000 | 0.50% |
Apex Capital Management | 1,096,757 | $17,998,000 | 0.41% |
AlphaMark Advisors, LLC | 42,651 | $700,000 | 0.39% |